ArticleBMC pulmonary medicine2024

Impact of immune checkpoint inhibitors (ICIs) therapy on interferon-γ release assay (IGRA) and diagnostic value in non-small cell lung cancer (NSCLC) patients.

Yijiao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.